Intco Medical Technology (300677.SZ) plans to spend 80-120 million yuan to repurchase shares.
Yingke Medical (300677.SZ) announcement, the company plans to use its own funds to repurchase a portion through centralized bidding...
Intco Medical Technology (300677.SZ) announced that the company plans to use its own funds to repurchase some of its company shares through centralized bidding trading (RMB ordinary shares (A shares)) for the implementation of an employee stock ownership plan and/or equity incentive. The total amount of repurchase funds will not be less than RMB 80 million (inclusive) and not more than RMB 120 million (inclusive), with a repurchase price limit of RMB 26.66 per share (inclusive).
Related Articles

"The 'Sky-high Monkey' Returns to CRO, will the 20cm Big Red Pillar sound the charge for Joinn Laboratories (06127) stock price to rebound?"

Sinolink: Policy + Technology + Performance Triple Inflection Point. Commercial Aerospace meets Singularity Moment.

New stock news | Oudong New Energy submitted an application to the Hong Kong Stock Exchange, becoming China's largest independent third-party electric exchange solution provider.
"The 'Sky-high Monkey' Returns to CRO, will the 20cm Big Red Pillar sound the charge for Joinn Laboratories (06127) stock price to rebound?"

Sinolink: Policy + Technology + Performance Triple Inflection Point. Commercial Aerospace meets Singularity Moment.

New stock news | Oudong New Energy submitted an application to the Hong Kong Stock Exchange, becoming China's largest independent third-party electric exchange solution provider.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


